Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
- Lara, P.C.
- Rodríguez-Melcón, J.I.
- Palacios-Eito, A.
- Lozano, A.
- Hervás-Morón, A.
- Villafranca, E.
- Gómez-Iturriaga, A.
- Sancho, G.
- Maldonado, X.
Zeitschrift:
Frontiers in Oncology
ISSN: 2234-943X
Datum der Publikation: 2022
Ausgabe: 12
Art: Artikel
